Cellulose-based cryogels for long-term culture of pancreatic islets and skeletal muscle tissue Ferran Velasco, Biosensors for Bioengineering Islet encapsulation inside traditional hydrogels is one of the most common techniques to … Read more
Cellulose-based cryogels for long-term culture of pancreatic islets and skeletal muscle tissue Ferran Velasco, Biosensors for Bioengineering Islet encapsulation inside traditional hydrogels is one of the most common techniques to … Read more
Cellulose-based cryogels for long-term culture of pancreatic islets and skeletal muscle tissue Ferran Velasco, Biosensors for Bioengineering Islet encapsulation inside traditional hydrogels is one of the most common techniques to … Read more
On the occasion of the annual meeting of the centres of excellence “Severo Ochoa and Maria de Maeztu” (SOMMa) at the 100xCiencia event, held in San Sebastián on November 22 and 23, Elisabeth Engel spoke on radio Euskadi about the intelligent devices they are developing in their laboratory. These bandages release nanoparticles containing calcium ions that are able to heal chronic lesions such as ulcers.
Despite significant advances in cancer diagnosis and treatment, most targeted cancer therapies fail to achieve complete tumor regressions or durable remission. Understanding why these treatments are not always efficient has remained a main challenge for researchers and physicians. Now, Joan Montero from the IBEC and colleagues at Dana-Farber Cancer Institute/Harvard Medical School in USA report in Nature Communications a mechanism that uncovers why some therapies fail to treat melanoma.
Yesterday, the Innovative Companies Forum (“FEI”, in Spanish) celebrated the seventh edition of the 2019 “Innovation Awards”. The awards ceremony, which aims to highlight the commitment to innovation of organizations, companies and researchers, recognized the Institute for Bioengineering of Catalonia’s (or “IBEC”) “Innovation Support Agency”. David Badia, executive director of the institute, received the award during the ceremony, which took place in Madrid. During his acceptance speech, Badia noted that IBEC is accredited as a Severo Ochoa Centre of Excellence and is dedicated to the field of bioengineering, with the objective not only to study, but to also promote the research’s application in the field of medicine, health and the improvement of people’s quality of life.
Group: Cellular and molecular mechanobiology and Pluripotency for organ regeneration. Group leader: Pere Roca-Cusachs (proca@ibecbarcelona.eu) and Núria Montserrat (nmontserrat@ibecbarcelona.eu) Research project The Cellular and Molecular Mechanobiology lab at IBEC studies … Read more
Group: Mechanics of development and disease and Biomimetic systems for cell engineering Group leader: Vito Conte (vconte@ibecbarcelona.eu) and Elena Martinez (emartinez@ibecbarcelona.eu) Research project Epithelia play an instrumental role in the genesis … Read more
As a part of IBEC’s strategy to facilitate the transfer of excellent science into health solutions for patients and hospitals, the Institute fosters relations and partnerships with clinicians and companies. Within this framework, the Institute of Bioengineering of Catalonia has now launched the IBEC Clinical Colloquia Program.Thanks to the nature of the research developed in the institute, IBEC counts on an ongoing and committed relationship with hospitals, medical doctors and patients. As a result, the involved partners are able to develop joint research projects, and in other cases they are a source of information about the unmet needs in clinical practice. With the launching of this clinical colloquia IBEC wants to strengthen these collaborations and offer the opportunity to create a space for discussion between researchers and medical doctors.
IBEC counts on collaboration of medical doctors to provide input on the clinical aspects of its research, so that results are easily extended to clinical practice.